Related Experiment Video
Updated: Jul 15, 2026

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
Identification of a universal Group B streptococcus vaccine by multiple genome screen
Domenico Maione1, Immaculada Margarit, Cira D Rinaudo
1Chiron srl, Via Fiorentina 1, 53100 Siena, Italy.
Abstract:
Group B Streptococcus (GBS) is a multiserotype bacterial pathogen representing a major cause of life-threatening infections in newborns. To develop a broadly protective vaccine, we analyzed the genome sequences of eight GBS isolates and cloned and tested 312 surface proteins as vaccines. Four proteins elicited protection in mice, and their combination proved highly protective against a large panel of strains, including all circulating serotypes. Protection also correlated with antigen accessibility on the bacterial surface and with the induction of opsonophagocytic antibodies. Multigenome analysis and screening described here represent a powerful strategy for identifying potential vaccine candidates against highly variable pathogens.
Related Concept Videos
Antibiotic Selection
Microorganisms in Medicine and Therapeutics
Methods of Classification and Identification
Modern Molecular Taxonomy
Applications of Molecular Taxonomy
Bacterial Gastroenteritis

